Skip to main content
Nature Communications logoLink to Nature Communications
. 2018 Jan 8;9:153. doi: 10.1038/s41467-017-02302-9

Author Correction: Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer

Zheng Han 1,#, Xiaohui Wu 1,#, Sarah Roelle 1, Chuheng Chen 1, William P Schiemann 2, Zheng-Rong Lu 1,2,
PMCID: PMC5758778  PMID: 29311548

Correction to: Nature Communications 10.1038/s41467-017-00741-y, Article published online 25 September 2017

In the original version of this Article, the penultimate sentence of the Abstract incorrectly read ‘The dose of the contrast agent for effective molecular MRI is only slightly lower than that of ZD2-Cy5.5 (0.5 µmol kg−1) in fluorescence imaging.’ The correct version states ‘higher’ in place of ‘lower’. This error has been corrected in both the PDF and HTML versions of the Article.

Footnotes

Zheng Han and Xiaohui Wu contributed equally to this work.

The original article can be found online at 10.1038/s41467-017-00741-y.

The original article can be found online at https://doi.org/10.1038/s41467-017-00741-y.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES